(SWBI) Smith & Wesson Brands - Overview
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US8317541063
Stock: Firearms, Handguns, Rifles, Accessories
Total Rating 50
Risk 87
Buy Signal 0.49
| Risk 5d forecast | |
|---|---|
| Volatility | 42.6% |
| Relative Tail Risk | -31.2% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.50 |
| Alpha | 5.57 |
| Character TTM | |
|---|---|
| Beta | 0.565 |
| Beta Downside | 0.795 |
| Drawdowns 3y | |
|---|---|
| Max DD | 54.24% |
| CAGR/Max DD | 0.17 |
EPS (Earnings per Share)
Revenue
Description: SWBI Smith & Wesson Brands March 05, 2026
Smith & Wesson Brands, Inc. (SWBI) designs, manufactures, and sells firearms globally. Their product range includes handguns, long guns, handcuffs, and suppressors. The company also provides manufacturing services to other businesses.
The firearms industry is subject to significant regulatory oversight. SWBI sells to a diverse customer base, including individual consumers, law enforcement, and military agencies. The company utilizes a multi-channel distribution strategy, including independent dealers, retailers, and direct-to-consumer sales.
SWBIs business model involves both product sales and manufacturing services, diversifying its revenue streams within the broader leisure products sector. Further analysis on ValueRay can provide deeper insights into SWBIs performance metrics and market position.
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income: 9.90m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA 5.47 > 1.0 |
| NWC/Revenue: 46.02% < 20% (prev 44.47%; Δ 1.54% < -1%) |
| CFO/TA 0.09 > 3% & CFO 50.1m > Net Income 9.90m |
| Net Debt (101.1m) to EBITDA (52.0m): 1.94 < 3 |
| Current Ratio: 4.98 > 1.5 & < 3 |
| Outstanding Shares: last quarter (44.7m) vs 12m ago -0.44% < -2% |
| Gross Margin: 25.93% > 18% (prev 0.30%; Δ 2562 % > 0.5%) |
| Asset Turnover: 82.11% > 50% (prev 87.61%; Δ -5.50% > 0%) |
| Interest Coverage Ratio: 3.53 > 6 (EBITDA TTM 52.0m / Interest Expense TTM 5.66m) |
Altman Z'' 8.83
| A: 0.39 (Total Current Assets 268.5m - Total Current Liabilities 53.9m) / Total Assets 548.6m |
| B: 0.95 (Retained Earnings 519.5m / Total Assets 548.6m) |
| C: 0.04 (EBIT TTM 20.0m / Avg Total Assets 568.0m) |
| D: 2.80 (Book Value of Equity 519.5m / Total Liabilities 185.4m) |
| Altman-Z'' Score: 8.83 = AAA |
Beneish M -3.06
| DSRI: 0.88 (Receivables 48.4m/60.8m, Revenue 466.4m/514.6m) |
| GMI: 1.17 (GM 25.93% / 30.21%) |
| AQI: 1.10 (AQ_t 0.07 / AQ_t-1 0.06) |
| SGI: 0.91 (Revenue 466.4m / 514.6m) |
| TATA: -0.07 (NI 9.90m - CFO 50.1m) / TA 548.6m) |
| Beneish M-Score: -3.06 (Cap -4..+1) = AA |
What is the price of SWBI shares?
As of March 05, 2026, the stock is trading at USD 12.01 with a total of 352,601 shares traded.
Over the past week, the price has changed by +2.13%, over one month by +3.27%, over three months by +36.47% and over the past year by +17.95%.
Over the past week, the price has changed by +2.13%, over one month by +3.27%, over three months by +36.47% and over the past year by +17.95%.
Is SWBI a buy, sell or hold?
Smith & Wesson Brands has received a consensus analysts rating of 4.33.
Therefore, it is recommended to buy SWBI.
- StrongBuy: 2
- Buy: 0
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the SWBI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 13.5 | 12.4% |
| Analysts Target Price | 13.5 | 12.4% |
SWBI Fundamental Data Overview March 04, 2026
P/E Trailing = 57.3333
P/S = 1.1486
P/B = 1.4737
Revenue TTM = 466.4m USD
EBIT TTM = 20.0m USD
EBITDA TTM = 52.0m USD
Long Term Debt = 89.0m USD (from longTermDebt, last quarter)
Short Term Debt = 1.78m USD (from shortTermDebt, last quarter)
Debt = 123.6m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 101.1m USD (from netDebt column, last quarter)
Enterprise Value = 632.0m USD (535.7m + Debt 123.6m - CCE 27.3m)
Interest Coverage Ratio = 3.53 (Ebit TTM 20.0m / Interest Expense TTM 5.66m)
EV/FCF = 17.33x (Enterprise Value 632.0m / FCF TTM 36.5m)
FCF Yield = 5.77% (FCF TTM 36.5m / Enterprise Value 632.0m)
FCF Margin = 7.82% (FCF TTM 36.5m / Revenue TTM 466.4m)
Net Margin = 2.12% (Net Income TTM 9.90m / Revenue TTM 466.4m)
Gross Margin = 25.93% ((Revenue TTM 466.4m - Cost of Revenue TTM 345.5m) / Revenue TTM)
Gross Margin QoQ = 24.34% (prev 25.95%)
Tobins Q-Ratio = 1.15 (Enterprise Value 632.0m / Total Assets 548.6m)
Interest Expense / Debt = 1.60% (Interest Expense 1.98m / Debt 123.6m)
Taxrate = 36.25% (1.09m / 3.01m)
NOPAT = 12.7m (EBIT 20.0m * (1 - 36.25%))
Current Ratio = 4.98 (Total Current Assets 268.5m / Total Current Liabilities 53.9m)
Debt / Equity = 0.34 (Debt 123.6m / totalStockholderEquity, last quarter 363.2m)
Debt / EBITDA = 1.94 (Net Debt 101.1m / EBITDA 52.0m)
Debt / FCF = 2.77 (Net Debt 101.1m / FCF TTM 36.5m)
Total Stockholder Equity = 366.0m (last 4 quarters mean from totalStockholderEquity)
RoA = 1.74% (Net Income 9.90m / Total Assets 548.6m)
RoE = 2.71% (Net Income TTM 9.90m / Total Stockholder Equity 366.0m)
RoCE = 4.39% (EBIT 20.0m / Capital Employed (Equity 366.0m + L.T.Debt 89.0m))
RoIC = 2.78% (NOPAT 12.7m / Invested Capital 458.8m)
WACC = 6.69% (E(535.7m)/V(659.3m) * Re(8.0%) + D(123.6m)/V(659.3m) * Rd(1.60%) * (1-Tc(0.36)))
Discount Rate = 8.0% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.77%
[DCF] Terminal Value 76.59% ; FCFF base≈24.7m ; Y1≈16.2m ; Y5≈7.38m
[DCF] Fair Price = 1.98 (EV 189.3m - Net Debt 101.1m = Equity 88.1m / Shares 44.5m; r=6.69% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: -61.26 | EPS CAGR: -45.69% | SUE: -0.74 | # QB: 0
Revenue Correlation: -33.02 | Revenue CAGR: -9.02% | SUE: 0.13 | # QB: 0
EPS next Year (2027-04-30): EPS=0.28 | Chg7d=+0.000 | Chg30d=+0.000 | Revisions Net=+0 | Growth EPS=+12.0% | Growth Revenue=+3.2%
P/S = 1.1486
P/B = 1.4737
Revenue TTM = 466.4m USD
EBIT TTM = 20.0m USD
EBITDA TTM = 52.0m USD
Long Term Debt = 89.0m USD (from longTermDebt, last quarter)
Short Term Debt = 1.78m USD (from shortTermDebt, last quarter)
Debt = 123.6m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 101.1m USD (from netDebt column, last quarter)
Enterprise Value = 632.0m USD (535.7m + Debt 123.6m - CCE 27.3m)
Interest Coverage Ratio = 3.53 (Ebit TTM 20.0m / Interest Expense TTM 5.66m)
EV/FCF = 17.33x (Enterprise Value 632.0m / FCF TTM 36.5m)
FCF Yield = 5.77% (FCF TTM 36.5m / Enterprise Value 632.0m)
FCF Margin = 7.82% (FCF TTM 36.5m / Revenue TTM 466.4m)
Net Margin = 2.12% (Net Income TTM 9.90m / Revenue TTM 466.4m)
Gross Margin = 25.93% ((Revenue TTM 466.4m - Cost of Revenue TTM 345.5m) / Revenue TTM)
Gross Margin QoQ = 24.34% (prev 25.95%)
Tobins Q-Ratio = 1.15 (Enterprise Value 632.0m / Total Assets 548.6m)
Interest Expense / Debt = 1.60% (Interest Expense 1.98m / Debt 123.6m)
Taxrate = 36.25% (1.09m / 3.01m)
NOPAT = 12.7m (EBIT 20.0m * (1 - 36.25%))
Current Ratio = 4.98 (Total Current Assets 268.5m / Total Current Liabilities 53.9m)
Debt / Equity = 0.34 (Debt 123.6m / totalStockholderEquity, last quarter 363.2m)
Debt / EBITDA = 1.94 (Net Debt 101.1m / EBITDA 52.0m)
Debt / FCF = 2.77 (Net Debt 101.1m / FCF TTM 36.5m)
Total Stockholder Equity = 366.0m (last 4 quarters mean from totalStockholderEquity)
RoA = 1.74% (Net Income 9.90m / Total Assets 548.6m)
RoE = 2.71% (Net Income TTM 9.90m / Total Stockholder Equity 366.0m)
RoCE = 4.39% (EBIT 20.0m / Capital Employed (Equity 366.0m + L.T.Debt 89.0m))
RoIC = 2.78% (NOPAT 12.7m / Invested Capital 458.8m)
WACC = 6.69% (E(535.7m)/V(659.3m) * Re(8.0%) + D(123.6m)/V(659.3m) * Rd(1.60%) * (1-Tc(0.36)))
Discount Rate = 8.0% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.77%
[DCF] Terminal Value 76.59% ; FCFF base≈24.7m ; Y1≈16.2m ; Y5≈7.38m
[DCF] Fair Price = 1.98 (EV 189.3m - Net Debt 101.1m = Equity 88.1m / Shares 44.5m; r=6.69% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: -61.26 | EPS CAGR: -45.69% | SUE: -0.74 | # QB: 0
Revenue Correlation: -33.02 | Revenue CAGR: -9.02% | SUE: 0.13 | # QB: 0
EPS next Year (2027-04-30): EPS=0.28 | Chg7d=+0.000 | Chg30d=+0.000 | Revisions Net=+0 | Growth EPS=+12.0% | Growth Revenue=+3.2%